Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Modern Rheumatology|October 14, 2006
Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosisToshiro Sugimoto, Mariko Soumura, Kiichiro Danno, et al.Biochemical and Biophysical Research Communications|February 25, 2006
N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulatorsKeizo Kanasaki, Masakazu Haneda, Toshiro Sugimoto, et al.The American Journal of Pathology|May 28, 2005
Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db miceMasami Chin, Motohide Isono, Keiji Isshiki, et al.Free Radical Biology & Medicine|June 21, 2006
Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylationShinji Kume, Masakazu Haneda, Keizo Kanasaki, et al.The Journal of Clinical Investigation|March 26, 2010
Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidneyShinji Kume, Takashi Uzu, Kihachiro Horiike, et al.The American Journal of the Medical Sciences|June 17, 2008
A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritisToshiro Sugimoto, Jun Ito, Naoko Takeda, et al.Diabetes|March 16, 2007
Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetesShin-ichi Araki, Masakazu Haneda, Daisuke Koya, et al.The Journal of Biological Chemistry|November 14, 2006
SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylationShinji Kume, Masakazu Haneda, Keizo Kanasaki, et al.Diabetes Care|July 30, 2010
Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuriaShin-ichi Araki, Masakazu Haneda, Daisuke Koya, et al.Diabetes|March 1, 2005
N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db miceKazuyuki Shibuya, Keizo Kanasaki, Motohide Isono, et al.Pageof 6